Rejoinder: Improving precision and power in randomized trials for COVID-19 treatments using covariate adjustment, for binary, ordinal, and time-to-event outcomes

Rejoinder: Improving precision and power in randomized trials for COVID-19 treatments using covariate adjustment, for binary, ordinal, and time-to-event outcomes

Bibliographic Details
Main Authors: Benkeser, D. (Author), Díaz, I. (Author), Luedtke, A. (Author), Rosenblum, M. (Author), Scharfstein, D. (Author), Segal, J. (Author)
Format: Article
Language:English
Published: John Wiley and Sons Inc 2021
Subjects:
biology
COVID-19
Data Interpretation, Statistical
disease control
drug
drug therapy
health risk
human
Humans
randomized controlled trial (topic)
Randomized Controlled Trials as Topic
SARS-CoV-2
statistical analysis
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items